EP3572405
Bensóimídasól-1,2-ýl-amíð sem Kv7-gangavirkjar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.9.2015EP published:
26.7.2023EP application number:
19185319.1
EP translation filed:
25.9.2023Grant published:
15.10.2023EPO information:
European Patent Register
Max expiry date:
13.9.2035Expiry date:
13.9.2026Next due date:
30.9.2026
Title in English:
BENZOIMIDAZOL-1,2-YL AMIDES AS KV7 CHANNEL ACTIVATORSLanguage of the patent:
English
Timeline
Today
14.9.2015EP application
26.7.2023EP Publication
25.9.2023Translation submitted
15.10.2023Registration published
13.9.2026Expires
Owner
Name:
Biohaven Therapeutics Ltd.Address:
215 Church Street, New Haven, CT 06510, US
Inventor
Name:
RESNICK, LynnAddress:
Pittsburgh, Pennsylvania 15241, US
Name:
TOPALOV, George TAddress:
Pittsburgh, Pennsylvania 15241, US
Name:
BOYD, Steven A.Address:
Mars, Pennsylvania 16046, US
Name:
BELARDI, Justin K.Address:
Pittsburgh, Pennsylvania 15237, US
Name:
FLENTGE, Charles A.Address:
Mars, Pennsylvania 16046, US
Name:
HALE, James S.Address:
Glenshaw, Pennsylvania 15116, US
Name:
HARRIED, Scott S.Address:
Sun Prairie, Wisconsin 53590, US
Name:
MARESKA, David A.Address:
McMurray, Pennsylvania 15317, US
Name:
ZHANG, KaiAddress:
Wexford, Pennsylvania 15090, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462050023 PDate:
12.9.2014Country:
US
Classification
Categories:
C07D 235/22
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 25.9.2023
Expires: 13.9.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.8.2024
Expires: 13.9.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 10.9.2025
Expires: 13.9.2026
Payer: Árnason Faktor ehf.